Voya Investment Management LLC lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 28.8% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 227,399 shares of the company’s stock after selling 91,938 shares during the period. Voya Investment Management LLC owned 0.14% of Option Care Health worth $7,948,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. Northwestern Mutual Wealth Management Co. raised its stake in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company’s stock valued at $31,000 after buying an additional 836 shares during the period. Brooklyn Investment Group increased its holdings in shares of Option Care Health by 186.6% during the 1st quarter. Brooklyn Investment Group now owns 1,198 shares of the company’s stock worth $42,000 after acquiring an additional 780 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in shares of Option Care Health by 21.6% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after acquiring an additional 332 shares during the last quarter. Bessemer Group Inc. raised its stake in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock valued at $54,000 after acquiring an additional 599 shares during the period. Finally, Wealthquest Corp acquired a new stake in Option Care Health during the 1st quarter valued at $66,000. Institutional investors and hedge funds own 98.05% of the company’s stock.
Option Care Health Price Performance
Shares of Option Care Health stock opened at $28.03 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The stock has a market capitalization of $4.55 billion, a price-to-earnings ratio of 22.42, a price-to-earnings-growth ratio of 1.68 and a beta of 0.82. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a 50-day simple moving average of $28.91 and a two-hundred day simple moving average of $31.33.
Wall Street Analyst Weigh In
OPCH has been the topic of several research reports. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a report on Thursday, July 31st. Citigroup reissued an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, Barrington Research restated an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Thursday, July 10th. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, Option Care Health presently has an average rating of “Moderate Buy” and an average target price of $35.75.
Read Our Latest Research Report on Option Care Health
Insider Buying and Selling at Option Care Health
In related news, Director Timothy P. Sullivan bought 20,000 shares of the business’s stock in a transaction dated Thursday, August 21st. The stock was purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the transaction, the director owned 49,229 shares in the company, valued at $1,354,289.79. The trade was a 68.43% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of the firm’s stock in a transaction that occurred on Tuesday, September 9th. The stock was bought at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the transaction, the director directly owned 15,501 shares of the company’s stock, valued at $454,334.31. This trade represents a 28.21% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 59,411 shares of company stock valued at $1,627,576 in the last three months. Corporate insiders own 0.64% of the company’s stock.
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Recommended Stories
- Five stocks we like better than Option Care Health
- How to Buy Cheap Stocks Step by Step
- Biotech Breakouts: 3 Stocks With Massive Upside Potential
- 3 Small Caps With Big Return Potential
- Powering Up: A Buy Rating Signals GE Vernova’s AI Tailwinds
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- The Side of Rate Cuts Nobody Is Telling You About
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.